These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 15082107)

  • 1. The focality of the global Alzheimer brain process: is the selective vulnerability of neurons a specific phenomenon of primary neuronal pathobiology?
    Agius LM
    Med Hypotheses; 2004; 62(5):783-7. PubMed ID: 15082107
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Neuroglia in neurodegeneration.
    Heneka MT; Rodríguez JJ; Verkhratsky A
    Brain Res Rev; 2010 May; 63(1-2):189-211. PubMed ID: 19944719
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Tauopathy and Alzheimer disease: a full degenerating process].
    Buée L; Delacourte A
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4(4):261-73. PubMed ID: 17194646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular pathways leading to neuronal dysfunction and degeneration.
    Kazantsev AG
    Drug News Perspect; 2007 Oct; 20(8):501-9. PubMed ID: 18080037
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's disease as a disorder of dynamic brain self-organization.
    Arendt T
    Prog Brain Res; 2005; 147():355-78. PubMed ID: 15581717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of hippocampal degeneration in amyotrophic lateral sclerosis with or without memory impairment: distinction from Alzheimer disease.
    Takeda T; Uchihara T; Arai N; Mizutani T; Iwata M
    Acta Neuropathol; 2009 Jan; 117(1):35-44. PubMed ID: 19002475
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hippocampal neurons in pre-clinical Alzheimer's disease.
    West MJ; Kawas CH; Stewart WF; Rudow GL; Troncoso JC
    Neurobiol Aging; 2004 Oct; 25(9):1205-12. PubMed ID: 15312966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contribution of neural networks to Alzheimer disease's progression.
    Savioz A; Leuba G; Vallet PG; Walzer C
    Brain Res Bull; 2009 Oct; 80(4-5):309-14. PubMed ID: 19539730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuroinflammatory changes increase the impact of stressors on neuronal function.
    Piazza A; Lynch MA
    Biochem Soc Trans; 2009 Feb; 37(Pt 1):303-7. PubMed ID: 19143652
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Should Alzheimer's disease be equated with human brain ageing? A maladaptive interaction between brain evolution and senescence.
    Neill D
    Ageing Res Rev; 2012 Jan; 11(1):104-22. PubMed ID: 21763787
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuro-modulation, aminergic neuro-disinhibition and neuro-degeneration. Draft of a comprehensive theory for Alzheimer disease.
    Schmitt HP
    Med Hypotheses; 2005; 65(6):1106-19. PubMed ID: 16125326
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synaptic degeneration in Alzheimer's disease.
    Arendt T
    Acta Neuropathol; 2009 Jul; 118(1):167-79. PubMed ID: 19390859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The pathology of the substantia nigra in Alzheimer disease with extrapyramidal signs.
    Burns JM; Galvin JE; Roe CM; Morris JC; McKeel DW
    Neurology; 2005 Apr; 64(8):1397-403. PubMed ID: 15851730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Truncated tau at D421 is associated with neurodegeneration and tangle formation in the brain of Alzheimer transgenic models.
    Zhang Q; Zhang X; Sun A
    Acta Neuropathol; 2009 Jun; 117(6):687-97. PubMed ID: 19190923
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional activation imaging in aging and dementia.
    Prvulovic D; Van de Ven V; Sack AT; Maurer K; Linden DE
    Psychiatry Res; 2005 Nov; 140(2):97-113. PubMed ID: 16257186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gray matter involvement in multiple sclerosis.
    Pirko I; Lucchinetti CF; Sriram S; Bakshi R
    Neurology; 2007 Feb; 68(9):634-42. PubMed ID: 17325269
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A new insight on Al-maltolate-treated aged rabbit as Alzheimer's animal model.
    Bharathi ; Shamasundar NM; Sathyanarayana Rao TS; Dhanunjaya Naidu M; Ravid R; Rao KS
    Brain Res Rev; 2006 Sep; 52(2):275-92. PubMed ID: 16782202
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum amyloid P component induces TUNEL-positive nuclei in rat brain after intrahippocampal administration.
    Urbányi Z; Sass M; Laszy J; Takács V; Gyertyán I; Pázmány T
    Brain Res; 2007 May; 1145():221-6. PubMed ID: 17337265
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Re-entry into the cell cycle: a mechanism for neurodegeneration in Alzheimer disease.
    McShea A; Wahl AF; Smith MA
    Med Hypotheses; 1999 Jun; 52(6):525-7. PubMed ID: 10459833
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between hippocampal volume and CA1 neuron loss in brains of humans with and without Alzheimer's disease.
    Kril JJ; Hodges J; Halliday G
    Neurosci Lett; 2004 May; 361(1-3):9-12. PubMed ID: 15135880
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.